APYX News and Press, Apyx Medical Corporation From 01/29/26

CLEARWATER, Fla., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (the “Company” or “Apyx Medical”), the leader in surgical aesthetics marketed and sold as Renuvion ® and the AYON Body Contouring System™ (AYON), today announ...

2026-01-12 08:30:00 ET More on Apyx Medical Apyx Medical Corporation (APYX) Q3 2025 Earnings Call Transcript Apyx Medical Corporation (APYX) Virtual KOL Event Transcript Apyx Medical announces pricing of $10M offering of common stock Apyx Medical outlines $50...

CLEARWATER, Fla., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (Nasdaq: APYX) (the “Company” or “Apyx Medical”) the leader in surgical aesthetics marketed and sold as Renuvion ® and the AYON Body Contouring System™ (AYON), today reported pr...

2025-12-15 16:15:10 ET Roth Capital analyst issues BUY recommendation for APYX on December 15, 2025 09:05PM ET. APYX was trading at $3.82 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recommendations are : 7 - Buy, 1 - Hold ...

2025-12-11 18:26:13 ET Company Background InMode Ltd. ( INMD ) was founded in 2008 and is based in Israel. It is a global leader in non-/minimally invasive aesthetic medical products, which are based on their proprietary radiofrequency ((RF)) assisted lipolysis and deep subd...

2025-12-09 04:28:03 ET More on The Financial Select Sector SPDR® Fund ETF, The Industrial Select Sector SPDR® Fund ETF, etc. Read the full article on Seeking Alpha For further details see: AI adopters trade gaining steam; top stocks in AI adoption sectors

CLEARWATER, Fla., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (Nasdaq: APYX) (the “Company” or “Apyx Medical”) the leader in surgical aesthetics marketed and sold as Renuvion ® and the AYON Body Contouring System™ (AYON), today announ...

2025-11-18 08:10:55 ET More on Apyx Medical Apyx Medical Corporation (APYX) Q3 2025 Earnings Call Transcript Apyx Medical Corporation (APYX) Virtual KOL Event Transcript Apyx Medical announces pricing of $10M offering of common stock Apyx Medical outlines $50...

2025-11-18 08:08:43 ET More on Apyx Medical Apyx Medical Corporation (APYX) Q3 2025 Earnings Call Transcript Apyx Medical Corporation (APYX) Virtual KOL Event Transcript Apyx Medical outlines $50.5M–$52.5M 2025 revenue target, signals AYON launch momentum ...

CLEARWATER, Fla., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (Nasdaq: APYX) (the “Company” or “Apyx Medical”) the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), today announced t...